The evolving culture of medical cannabis in Canada for the management of chronic pain
Abstract Although used therapeutically for millennia, cannabis has been a prohibited substance worldwide for most of the 20th Century. With…
chronic beryllium disease
Pneumoconiosis with a Sarcoid-Like Reaction Other than Beryllium Exposure: A Case Report and Literature Review
Abstract Background: Chronic beryllium disease (CBD) is a granulomatous disease that resembles sarcoidosis but is caused by beryllium. Clinical manifestations…
Interstitial pneumonia in a glassblower: think to chronic beryllium disease!
Abstract Chronic beryllium disease (CBD) is an occupational illness with varying severity. In this report, we describe a 27 year…
Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach
Abstract Cannabinoids have shown diverse and critical effects on the body systems, which alter the physiological functions. Synthetic cannabinoids are…
Advances in Identifying Beryllium Sensitization and Disease
Abstract Beryllium is a lightweight metal with unique qualities related to stiffness, corrosion resistance, and conductivity. While there are many…
A Reconsideration of Acute Beryllium Disease
Abstract Context: Although chronic beryllium disease (CBD) is clearly an immune-mediated granulomatous reaction to beryllium, acute beryllium disease (ABD) is…
Progression from Beryllium Exposure to Chronic Beryllium Disease: An Analytic Model
Abstract Background: Understanding the progression from beryllium exposure (BeE) to chronic beryllium disease (CBD) is essential for optimizing screening and…
Chronic Beryllium Disease and Sensitization at a Beryllium Processing Facility
Abstract We conducted a medical screening for beryllium disease of 577 former workers from a beryllium processing facility. The screening…